Modelling Meningioma Using Organoids: A Review of Methodologies and Applications
Open Access
Abstract
Meningiomas are the most common tumours of the central nervous system. According to the World Health Organization (WHO), this disease is classified into three different grades: 80% of meningioma patients present with benign grade I tumours, while less than 2% present with malignant grade III meningiomas. Despite affecting thousands of people worldwide, much remains unknown about this disease, and the development of systemic treatments is still far behind in comparison to other types of tumours. Therefore, forming 3D structures (spheroids and organoids) could facilitate research on the mechanisms of formation, proliferation, migration, and invasion of these, for the most part, benign tumours, while also helping in the process of drug development. To date, there are three published methods for the formation of meningioma organoids primarily derived from patient tissue samples. Organoids offer many advantages in the development of treatments because they recapitulate the cellular complexity within tumours. These new methodological advances could open a substantial number of possibilities for the further characterisation and treatment of meningiomas. This review includes an overview of the disease and a description and comparison of established protocols for meningioma organoid formation.Keywords
This publication has 73 references indexed in Scilit:
- Loss of SUFU Function in Familial Multiple MeningiomaThe American Journal of Human Genetics, 2012
- Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutationFamilial Cancer, 2012
- DUSPs, to MAP kinases and beyondCell & Bioscience, 2012
- Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypesOncogene, 2011
- Epidemiology and etiology of meningiomaJournal of Neuro-Oncology, 2010
- Psammoma body: A product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor?Diagnostic Cytopathology, 2009
- Characterization of Arachnoidal Cells Cultured on Three-Dimensional Nonwoven PET MatrixTissue Engineering, 2007
- Mutational spectrum of theNF2gene: a meta-analysis of 12 years of research and diagnostic laboratory findingsHuman Mutation, 2007
- Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomasGenes, Chromosomes and Cancer, 2004
- Rapid Growth of a Meningioma during Pregnancy: Relationship with Estrogen and Progesterone ReceptorsNeurologia medico-chirurgica, 1989